SP-D (surfactant protein D, expressed by type II alveolar cells and involved in innate immunity on all mucosal surfaces, was found to be a bacterial species-specific differentiating factor in children with VAP. This evidence concerns the gene SFTPD and ventilator-associated pneumonia.